Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 16, Number 1—January 2010

Dispatch

Hepatitis E Epidemic, Uganda

Eyasu H. TeshaleComments to Author , Christopher M. Howard, Scott P. Grytdal, Thomas R. Handzel, Vaughn Barry, Saleem Kamili, Jan Drobeniuc, Samuel Okware, Robert Downing, Jordan W. Tappero, Barnabas Bakamutumaho, Chong-Gee Teo, John W. Ward, Scott D. Holmberg, and Dale J. Hu
Author affiliations: Centers for Disease Control and Prevention, Atlanta, Georgia, USA (E.H. Teshale, C.M. Howard, S.P. Grytdal, T.R. Handzel, V. Barry, S. Kamili, J. Drobeniuc, C.-G. Teo, J.W. Ward, S.D. Holmberg, D.J. Hu); Ministry of Health, Republic of Uganda, Kampala, Uganda (S. Okware); Global AIDS Program, Kampala (R. Downing, J.W. Tappero); Ugandan Virus Research Institute, Entebbe, Uganda (B. Bakamutumaho)

Main Article

Table

Symptomatic and serologic evidence of HEV infection, Uganda, June 2008

Characteristic Jaundice
HEV seropositivity
No. examined No. (%) with jaundice No. tested No. (%) seropositive
Age group, y





<2
1,352
92 (6.8)

23
7 (30.4)
2–4
2,213
370 (16.7)

49
28 (57.1)
5–9
3,361
589 (17.5)

59
36 (61.0)
10–14
2,692
504 (18.7)

70
49 (70.0)
15–44
7,155
2,402 (33.6)

189
135 (71.4)
≥45
2,186
816 (37.3)

75
48 (64.0)
Sex





M
9,177
2,017 (22.0)

188
122 (64.9)
F
9,877
2769 (28.0)

277
180 (65.0)
Total 19,098 4789 (25.1) 469 305 (65.0)

*HEV, hepatitis E virus.

Main Article

TOP